News
Aficamten is a small-molecule cardiac myosin inhibitor that was compared for the first time in the trial to the ...
Trial results for aficamten were presented to cardiologists over the weekend. One analyst said the drug could be ...
The items in your order may be shipped from any of the above jurisdictions. The products are sourced from various countries as well as those listed above. Rest assured, we only affiliate with our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results